Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor

M A Steller1, Z Zou, J T Schiller

  • 1Surgery Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

Cancer Research
|November 1, 1996
PubMed

Insights

Human papillomavirus-16 E6 and E7 proteins cooperate in malignant transformation. E7 requires insulin-like growth factor-1 receptor (IGF-1R) for transformation, while E6 can substitute for IGF-1R, suggesting a role in survival pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Human papillomavirus-16 (HPV-16) E6 and E7 proteins inactivate tumor suppressors p53 and pRB, respectively.
  • The downstream molecular events in HPV-16-mediated malignant transformation are not fully understood.
  • Insulin-like growth factor-1 receptor (IGF-1R) plays a role in cell survival and transformation.

Purpose of the Study:

  • To investigate the role of IGF-1R in HPV-16 E7-mediated cell transformation.
  • To determine if HPV-16 E6 can functionally substitute for IGF-1R in cell transformation.
  • To examine the role of E6 and IGF-1R in cellular apoptotic responses.

Main Methods:

  • Stable transfection of mouse fibroblast cell lines with HPV-16 E6 and E7 genes.
  • Assessing cell transformation potential using soft agar colony formation assays.
  • Evaluating apoptotic responses to staurosporine in wild-type and IGF-1R-deficient cells with or without E6/E7 expression.

Main Results:

  • E7-mediated transformation of wild-type cells was observed, but E7 alone did not transform IGF-1R-deficient cells.
  • Co-expression of E6 and E7 in IGF-1R-deficient cells resulted in significant colony formation.
  • Both E6 and IGF-1R conferred resistance to staurosporine-induced apoptosis, suggesting a functional equivalence in antiapoptotic roles.
  • E6 also suppressed apoptosis in p53-deficient cells, indicating a p53-independent antiapoptotic mechanism.

Conclusions:

  • Transformation by HPV-16 E7 requires the participation of IGF-1R.
  • HPV-16 E6 can functionally substitute for IGF-1R in E7-mediated transformation of IGF-1R-deficient cells.
  • Both IGF-1R and E6 likely promote cell survival by recruiting antiapoptotic pathways, contributing to malignant transformation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...